about
The human 20-kDa 5'-(CGG)(n)-3'-binding protein is targeted to the nucleus and affects the activity of the FMR1 promoterMCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-MAbnormal dendritic spines in fragile X knockout mice: maturation and pruning deficitsFragile X mental retardation protein is translated near synapses in response to neurotransmitter activationStructural Studies of the Tandem Tudor Domains of Fragile X Mental Retardation Related Proteins FXR1 and FXR2The fragile X mental retardation protein inhibits translation via interacting with mRNAArgonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects.Molecular and cellular genetics of fragile X syndrome.The effect of FMR1 CGG repeat interruptions on mutation frequency as measured by sperm typing.X inactivation of the FMR1 fragile X mental retardation geneFragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndromeFragile X mental retardation: misregulation of protein synthesis in the developing brain?Fragile X premutations are not a major cause of early menopause.Quantitative comparison of FMR1 gene expression in normal and premutation allelesAn atypical case of fragile X syndrome caused by a deletion that includes the FMR1 geneFragile X gene instability: anchoring AGGs and linked microsatellitesLarge domains of apparent delayed replication timing associated with triplet repeat expansion at FRAXA and FRAXE.Fragile X-related proteins regulate mammalian circadian behavioral rhythms.MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and Fragile X syndrome.Ionotropic glutamate receptors & CNS disorders.Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.Limbic epileptogenesis in a mouse model of fragile X syndrome.The microRNA pathway and fragile X mental retardation protein.Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of fragile X-associated tremor/ataxia syndromeMicroRNA implications across neurodevelopment and neuropathology.Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapsesHigh-throughput DNA diagnostic measurements using capillary electrophoresis: p53, fragile X and telomerase.Standardization of PCR amplification for fragile X trinucleotide repeat measurements.Trinucleotide repetition and fragile X syndrome.Screening for fragile X syndrome: information needs for health planners.FMR1 in global populationsStabilization of microsatellite sequences by variant repeats in the yeast Saccharomyces cerevisiae.Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.Haplotype Analysis of DXS548 and FRAXAC1 Microsatellite Loci in Iranian Patients with Fragile X Syndrome.Clinical description of an adult male with psychosis who showed FMR1 gene methylation mosaicism.Distribution of CGG repeats and FRAXAC1/DXS548 alleles in South American populations.Deletion of 8.5 Mb, including the FMR1 gene, in a male with the fragile X syndrome phenotype and overgrowth.Reverse mutations in the fragile X syndrome.
P2860
Q22253241-D3BC9941-47FB-4C4C-BAC1-6826863FA6C8Q24552865-24CD24F3-071A-4082-9087-6D5A57A1A22AQ24657867-88464F16-9C51-4457-B240-7CF4652A18EDQ24657890-B4796E08-7980-49FC-9920-9BF95B89339BQ27665857-E40519E6-CEA2-4E30-91C9-8EEB00FE76B6Q28588486-964B0382-4CFA-4127-A99C-F33C9A4432D4Q33514846-799DD9ED-84C6-4F8F-AC52-51C75C36AF01Q33537385-663EA051-6164-4B58-831C-40332A965929Q33679225-052D90BB-00DF-4641-AE38-4B47ADBEC793Q33682895-3D239971-1EC0-40EF-8D52-3B1F928648ADQ34044314-36CC4976-966F-4726-B33C-48CB40DC1F13Q34200046-E8BAF932-86B9-4948-BAC6-C7248DBBC37EQ34733363-6E7A1203-AC0E-4FD5-A5BD-A84FEECEC7BFQ35250296-676AF39E-68E1-4E0B-B7A5-BE7706161DA4Q35643830-D9878383-C43E-4F74-B663-8B3C1C0CD892Q35644285-494D486F-A38B-4710-81BD-F37C3BF09691Q35644624-23572C66-33A9-4871-B361-04D4225553E1Q35881984-86CA1DE7-DF5B-4EB4-9725-E08D401B94ABQ36744675-C24FB44D-9423-421C-9CCC-368828A92951Q36764198-1CCC2545-5171-41B4-8181-66216964BB6EQ37143580-114D0DED-30F3-4778-A311-3D65A168428DQ37190453-4F6C2988-DE85-4623-A3D2-6AC9502C0B3AQ37220443-53D9D77E-C636-45EB-B9C9-22813A4D09A9Q37238015-A0B236AB-91BC-42B3-87E2-2A0A9A089182Q37508604-43CC319E-5531-4FB7-BC94-17947F61DC78Q37617954-48C542F6-F441-4A0D-BE5B-F7A15643B080Q37713828-0382F441-0861-4F6C-B657-6EA7D4AD3A43Q38088835-446D5049-986D-44BF-802A-6AD7DA8E2BD8Q40743758-54B2A579-FE53-4CA1-A587-BC882E21DFFCQ41436322-20DADA54-AF20-4EA6-B5FE-28054C78912BQ41579814-68653C4E-BAF0-4226-971D-958259FDBB82Q41949795-187F90EA-1E7A-4634-A430-F37F95C8629DQ42967686-839FDEAF-9A7D-4586-8592-8FFEDC6F30CCQ46084368-753ED61E-859A-43E5-B299-8E652C8980C8Q47550933-55588832-7623-4392-8F7F-56C95D01CBCAQ48035470-E0510B93-A2CC-421A-8ABF-803D70087EBDQ51953579-4DA4DE6D-9F1D-4D7B-B89F-22681488EAA5Q51985532-84415B99-0D54-4B5C-A635-0FC1198B9611Q52200259-36ACC610-43D9-496F-B7F9-8EBCD19E1611
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Advances in molecular analysis of fragile X syndrome.
@en
type
label
Advances in molecular analysis of fragile X syndrome.
@en
prefLabel
Advances in molecular analysis of fragile X syndrome.
@en
P1476
Advances in molecular analysis of fragile X syndrome.
@en
P2093
D L Nelson
S T Warren
P304
P356
10.1001/JAMA.1994.03510310066040
P407
P577
1994-02-01T00:00:00Z